Brief: Defloria Commences Phase 1 Clinical Program For Full Spectrum Hemp Botanical Drug
13/12/2023 11:14
Dec 13 (Reuters) - Charlotte's Web Holdings Inc
CWEB.TO :
* DEFLORIA LLC COMMENCES PHASE 1 CLINICAL PROGRAM FOR
INNOVATIVE
FULL SPECTRUM HEMP BOTANICAL DRUG
* CHARLOTTE'S WEB HOLDINGS: FIRST COHORT WAS DOSED IN EARLY
SEPTEMBER AND DEFLORIA EXPECTS PRELIMINARY RESULTS IN Q1 OF 2024
Source text for Eikon: ID:nPn62bLPpa
Further company coverage: CWEB.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Charlotte's Web Holdings
See all newsCharlotte's Web Q2 revenue falls as retail exits weigh
Brief: Charlotte's Web Announces Transaction With Bat Debenture Conversion And US $10 Million Equity Investment To Strengthen Balance Sheet
Brief: Charlotte's Web Appoints M. Borgia Walker to Board of Directors
Brief: Charlotte's Web Appoints M. Borgia Walker to Board of Directors
Brief: Charlotte's Web Announces Plans To Establish A Scientific Advisory Board